INNOVAG®

INNOVAG® vaginal ovules with protective, restorative and soothing effect are recommended for the treatment and prevention of vaginosis and bacterial and fungal vaginitis. A unique formulation with chlorhexidine produces potent antiseptic effect on bacteria and fungi and thanks to the presence of natural extract of propolis rich in polyphenols, lactic and hyaluronic acid, INNOVAG® vaginal ovules promote regeneration of vaginal mucosa.

Chlorhexidine belongs to a group of compounds with strong local antiseptic action, which effectively prevents the growth and development of a large number of bacteria, fungi and viruses. Thanks to the unique mechanism of action, chlorhexidine binds to the cytoplasmic membrane of bacteria, fungi and certain viruses, leading to the decomposition and death of harmful microorganisms, thus reducing the symptoms and signs of inflammation. The sensitivity of many microorganisms to the action of chlorhexidine is high, and is not reduced by continuous topical use.

Propolis extract effectively prevents the growth and development of microorganisms, reduces inflammation of the vaginal mucosa, without adverse effects on the “good bacteria” of the vaginal microflora. Thanks to the presence of polyphenols, it contributes to improvement of the local immunity of the vaginal mucosa and increased body’s natural resistance.

Hyaluronic and lactic acid, together with aloe extract and vitamin E, form a protective barrier on the surface of the vaginal mucosa, which prevents the development of new infection, contributes to hydration, regeneration and faster wound healing, especially after surgery.

The synergistic effect of active principles ensures the renewal of the vaginal microflora and the establishment of optimal pH values of the vaginal mucosa.

In which conditions is the use of the product INNOVAG® vaginal ovules recommended?

Why INNOVAG®?

What do INNOVAG® vaginal ovules contain?

Active ingredients:
1 vaginal ovule (2 g)
Sodium hyaluronate
4 mg
Aloe leaf extract (Aloe barbadensis L.)
2 mg
Propolis extract (Pole S.)
4 mg
Tocopherol acetate
1 mg
Lactic acid
1,94 mg
Chlorhexidine hydrochloride
1 mg

Method of use and length of application:

Wash your hands carefully, take out one vaginal ovule and insert it deep into the vagina in a supine position, before bed.

INDICATIONS
Length of administration
Prevention and treatment of vaginosis and bacterial and fungal vaginitis
Prevention of recurrence of vaginal infections of bacterial and fungal origin
Establishing and maintaining the optimal pH value of the vagina
7 days
Before surgeries
According to the doctor’s advice
After surgeries
14 days

One vaginal ovule once a day.

Administration in pregnancy: INNOVAG® vaginal ovules can be used during pregnancy after consulting a doctor.

Notes: The product is clinically tested, free of parabens and thiazolinones, odourless, colourless and silicone free.

Packaging: 7 vaginal ovules.

Vaginalne infekcije

Zdrava vaginalna sluznica na svojoj površini sadrži brojne mikroorganizme, takozvane “dobre bakterije” koje održavaju vlažnost i optimalnu pH vrednost vagine, istovremeno štiteći vaginalnu sluznicu od nastanka nove infekcije. Zajednica različitih mikroorganizama koja se nalazi na površini vaginalne sluznice predstavlja složen i dinamičan ekosistem, pretežno sastavljen od bakterija iz roda Lactobacillus, koje proizvode mlečnu kiselinu, i dodatno štite vaginalnu sluznicu od štetnih mikroorganizama i infekcije. Zdrav vaginalni sekret ima higijensku ulogu i predstavlja normalnu pojavu kod polno zrelih žena i najčešće je proziran ili beličast. Izgled vaginalnog sekreta se menja tokom faza menstrualnog ciklusa, trudnoće, emocionalnog stresa, promene načina ishrane ili u toku uzimanja različitih lekova.

Vaginalne infekcije predstavljaju upalu vaginalne sluznice koja može da zahvati i spoljašnje ženske polne organe, a koje se ispoljavaju neprijatnim simptomima poput svraba, iritacije, bola i drugih tegoba. Učestalost vaginalnih infekcija varira u zavisnosti od brojnih faktora rizika, načina života kao i higijensko-dijetetskog režima.

Faktori rizika za nastanak vaginalnih infekcija su brojni i obuhvataju hormonske promene (trudnoća, kontraceptivne pilule ili menopauza), upotrebu različitih lekova (antibiotici, kortikosteroidi), neadekvatno lečenu šećernu bolest i brojna zdravstvena stanja sa oslabljenim imunim sistemom. Takodje, u faktore rizika spada i upotreba neadekvatnih sredstava za intimnu higijenu, kao i nošenje neudobnog veša ili odeće.

Najčešći uzročnici vaginalnih infekcija su različite vrste bakterija, od koji je najdominantnija bakterija iz roda Gardnerella, zatim gljivice, od kojih je najčešća Candida albicans, različiti paraziti, kao što je Trichomonas vaginalis, kao i pojedini virusi koji takođe mogu izazvati upalu vaginalne sluznice.

Simptomi vaginalnih infekcija se razlikuju u zavisnosti od vrste uzročnika, i podrazumevaju promene u izgledu vaginalnog iscedka, pojavu svraba, bola, neprijatnost u donjem delu stomaka, peckanje prilikom mokrenja, bol tokom seksulanih odnosa. Određen broj pacijentkinja nema nikakve simptome i upala se dijagnostikuje rutinskim preventivnim pregledima.

Dijagnoza se postavlja isključivo ginekološkim pregledom i određivanjem stepena vaginalne čistoće, koji se procenjuje na osnovu mikroskopskog pregleda vaginalnog sekreta i bakteriološkog nalaza.

Terapija vaginalnih infekcija proizilazi iz detaljne evaluacije simptomatologije, pregleda i laboratorijskih nalaza pacijentkinje, nakon čega se lekar opredeljuje za određeni lek ili medicinsko sredstvo.

Izazovi u lečenju infekcija vaginalne sluznice predstavljaju česte i ponavljane infekcije, koje narušavaju kvalitet života pacijentkinje, dovode do povećanog rizika za nastanak zapaljenskih bolesti karlice, polno prenosivih bolesti, kao i do nepovoljnih akušerskih i ginekoloških ishoda (prevremeni porođaj, upala posteljice i sl). Iz ovog razloga, važno je istaći značaj redovnih ginekoloških pregleda i pravovremenu dijagnozu vaginalnih infekcija.

Vaginal infections

Healthy vaginal mucosa contains numerous microorganisms on its surface, the so-called “good bacteria” that maintain the humidity and optimal pH value of the vagina, while protecting the vaginal mucosa from the development of new infections. The community of different microorganisms located on the surface of the vaginal mucosa is a complex and dynamic ecosystem, mostly composed of bacteria of the genus Lactobacillus, which produce lactic acid, and further protect the vaginal mucosa from harmful microorganisms and infection. Healthy vaginal secretion has a hygienic role and is a normal phenomenon in sexually mature women and is usually transparent or whitish. The appearance of vaginal secretions changes during the phases of the menstrual cycle, pregnancy, emotional stress, changes in diet or while taking various medications.

Vaginal infections are an inflammation of the vaginal mucosa that can also affect the external female genitalia, and which are manifested by unpleasant symptoms such as itching, irritation, pain and other symptoms. The frequency of vaginal infections varies depending on numerous risk factors, lifestyle and hygienic-dietary regime.

Risk factors for vaginal infections are numerous and include hormonal changes (pregnancy, birth control pills or menopause), use of various medications (antibiotics, corticosteroids), inadequately treated diabetes and numerous health conditions with a weakened immune system. Also, risk factors include the use of inadequate intimate hygiene products, as well as wearing uncomfortable underwear or clothes.

The most common causes of vaginal infections are different types of bacteria, the most dominant of which is the bacterium Gardnerella, then fungi, the most common of which is Candida albicans, various parasites such as Trichomonas vaginalis, and some viruses that can also cause inflammation of the vaginal mucosa.

Symptoms of vaginal infections vary depending on the type of causative agent, and include changes in the appearance of vaginal discharge, itching, pain, discomfort in the lower abdomen, tingling when urinating, pain during sexual intercourse. A number of patients have no symptoms and inflammation is diagnosed by routine preventive examinations.

The diagnosis is made exclusively by gynaecological examination and determination of the degree of vaginal cleanliness, which is assessed on the basis of microscopic examination of vaginal secretions and bacteriological findings.

The treatment of vaginal infections results from a detailed evaluation of the patient’s symptoms, examinations and laboratory findings, after which the doctor decides on a specific medicine or medical device.

Challenges in the treatment of vaginal mucosal infections are frequent and recurrent infections, which impair the patient’s quality of life, lead to increased risk of pelvic inflammatory disease, sexually transmitted diseases, as well as unfavourable obstetric and gynaecological outcomes (premature birth, placental inflammation, etc.). For this reason, it is important to emphasize the importance of regular gynaecological examinations and timely diagnosis of vaginal infections.